Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
NIST Releases Guidelines for Hospital-at-Home Security
Tech & Innovation NIST Releases Guidelines for Hospital-at-Home Security

The rapid expansion of telehealth has brought medical care directly into the living room, with smart speakers and other connected devices now serving as crucial links between patients and their healthcare providers. While this technological integration promises unprecedented convenience and

Hospitals Embrace AI for Revenue Despite Cost Hurdles
Management & Administration Hospitals Embrace AI for Revenue Despite Cost Hurdles

Amid relentless financial pressures and the persistent challenge of revenue leakage from documentation errors, a significant majority of American health systems are now turning to Generative AI as a critical tool for stabilizing their economic foundations. Recent findings from a comprehensive

How Can States Fix Medicaid for Patients and Taxpayers?
Management & Administration How Can States Fix Medicaid for Patients and Taxpayers?

The vast and complex Medicaid program, designed as a critical safety net for the nation’s most vulnerable citizens, is now grappling with structural flaws that threaten its long-term viability and strain public resources. Perverse financial incentives embedded within its joint federal-state funding

What Is a Hospital's Biggest Security Blind Spot?
Management & Administration What Is a Hospital's Biggest Security Blind Spot?

The rapid integration of connected medical devices into modern healthcare promises a new era of efficiency and improved patient outcomes, but it simultaneously introduces a pervasive and often overlooked vulnerability. A comprehensive analysis of the cybersecurity landscape in North American

Curitics Taps John Gorman to Bolster Health Tech Strategy
Management & Administration Curitics Taps John Gorman to Bolster Health Tech Strategy

In the rapidly evolving landscape of American healthcare, where the transition to value-based care models places immense pressure on providers and health plans, the integration of deep policy expertise with cutting-edge technology is no longer an advantage but a necessity. Curitics Health

Could This Device End Repeat Breast Cancer Surgeries?
Management & Administration Could This Device End Repeat Breast Cancer Surgeries?

For the tens of thousands of individuals undergoing breast-conserving surgery each year, the procedure represents a critical step toward recovery, but it often comes with a significant and distressing uncertainty. The goal of a lumpectomy is to remove the cancerous tumor along with a small margin

Report Reveals Deepening Elderly Care Crisis in South Korea
Care Providers Report Reveals Deepening Elderly Care Crisis in South Korea

A comprehensive new analysis has cast a harsh light on the rapidly escalating crisis within South Korea's elderly care system, revealing a critical failure to keep pace with a senior population that has swelled to over 10 million. The report, titled the "2025 Elderly Care Gap Index," meticulously

De Leon Redefines Corporate Wellness in the Philippines
Care Providers De Leon Redefines Corporate Wellness in the Philippines

In the Philippines, the traditional corporate approach to employee health, once a reactive measure addressing illness as it arose, is undergoing a profound transformation into a strategic imperative focused on proactive and holistic well-being. This paradigm shift reflects a growing understanding

Fixing Prior Authorization Starts With Providers
Management & Administration Fixing Prior Authorization Starts With Providers

The persistent friction of prior authorization has long been a source of frustration within the American healthcare system, often creating significant delays in patient care and burying clinicians under a mountain of administrative tasks. While the prevailing narrative has frequently positioned

FDA Approves First At-Home Device for Depression
Tech & Innovation FDA Approves First At-Home Device for Depression

Introduction The landscape of mental health treatment is undergoing a significant transformation, moving beyond traditional pharmaceuticals to embrace innovative technological solutions that offer new hope for millions. In a landmark decision, the U.S. Food and Drug Administration (FDA) has

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later